rs1803254
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001772.4(CD33):c.*201G>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.125 in 433,648 control chromosomes in the GnomAD database, including 5,573 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.16 ( 3114 hom., cov: 32)
Exomes 𝑓: 0.10 ( 2459 hom. )
Consequence
CD33
NM_001772.4 3_prime_UTR
NM_001772.4 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.152
Publications
21 publications found
Genes affected
CD33 (HGNC:1659): (CD33 molecule) Enables protein phosphatase binding activity and sialic acid binding activity. Involved in several processes, including negative regulation of cytokine production; negative regulation of monocyte activation; and positive regulation of protein tyrosine phosphatase activity. Located in several cellular components, including Golgi apparatus; external side of plasma membrane; and peroxisome. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 19-51239889-G-C is Benign according to our data. Variant chr19-51239889-G-C is described in ClinVar as Benign. ClinVar VariationId is 1282621.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.32 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.162 AC: 24626AN: 152010Hom.: 3101 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
24626
AN:
152010
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.104 AC: 29347AN: 281518Hom.: 2459 Cov.: 4 AF XY: 0.102 AC XY: 14816AN XY: 145642 show subpopulations
GnomAD4 exome
AF:
AC:
29347
AN:
281518
Hom.:
Cov.:
4
AF XY:
AC XY:
14816
AN XY:
145642
show subpopulations
African (AFR)
AF:
AC:
2031
AN:
7564
American (AMR)
AF:
AC:
3143
AN:
8158
Ashkenazi Jewish (ASJ)
AF:
AC:
724
AN:
9794
East Asian (EAS)
AF:
AC:
5888
AN:
21280
South Asian (SAS)
AF:
AC:
1451
AN:
15252
European-Finnish (FIN)
AF:
AC:
1314
AN:
22116
Middle Eastern (MID)
AF:
AC:
104
AN:
1388
European-Non Finnish (NFE)
AF:
AC:
12531
AN:
177982
Other (OTH)
AF:
AC:
2161
AN:
17984
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1147
2293
3440
4586
5733
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
122
244
366
488
610
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.162 AC: 24687AN: 152130Hom.: 3114 Cov.: 32 AF XY: 0.164 AC XY: 12185AN XY: 74382 show subpopulations
GnomAD4 genome
AF:
AC:
24687
AN:
152130
Hom.:
Cov.:
32
AF XY:
AC XY:
12185
AN XY:
74382
show subpopulations
African (AFR)
AF:
AC:
11489
AN:
41464
American (AMR)
AF:
AC:
5010
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
AC:
229
AN:
3472
East Asian (EAS)
AF:
AC:
1658
AN:
5170
South Asian (SAS)
AF:
AC:
498
AN:
4820
European-Finnish (FIN)
AF:
AC:
613
AN:
10610
Middle Eastern (MID)
AF:
AC:
28
AN:
294
European-Non Finnish (NFE)
AF:
AC:
4821
AN:
67990
Other (OTH)
AF:
AC:
309
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
962
1924
2886
3848
4810
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
234
468
702
936
1170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
748
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jun 19, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.